Work Should Not Hurt You: Reduction of Hazardous Exposures in Small Businesses Through a Community Health Worker Intervention
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Paloma S Beamer, PhD
- Phone Number: 5206260006
- Email: pbeamer@email.arizona.edu
Study Contact Backup
- Name: Dean Billheimer, PhD
- Phone Number: (520) 626-9902
- Email: dean.billheimer@arizona.edu
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85701
- Sonora Environmental Research Institute
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- workers or owners of small businesses in select sectors (e.g., beauty salons, auto shops) in target zip codes in southern metropolitan Tucson, Arizona
Exclusion Criteria:
- age less than 18 years or people not employed in targeted sectors
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Intervention Group
The intervention group will receive the IH-enhanced CHW intervention before (~3 months) the other arm (Delayed Intervention Group).
|
The intervention will be derived from audits and exposure assessments and focus groups with workers and owners in the same business types (excluded from the trial) conducted in an earlier part of the study, as well as a community advisory group (e.g., Hispanic Chamber of Commerce) .
From this, we will generate educational materials specific for each small business sector.
We will provide the CHWs with a list of industry-specific control options along with potential cost savings and benefits.
For example, EPA estimates a cost saving of $13,000 per year for auto body shops that switch to the high-velocity low-pressure spray guns.
Each list will be a comprehensive menu of options that contain multiple control measures including simple controls, such as keeping the lids on the solvent containers.
|
|
Other: Delayed Intervention Group
The delayed intervention group will receive the IH-enhanced CHW intervention after (~3 months) the other arm (Intervention Group).
|
The intervention will be derived from audits and exposure assessments and focus groups with workers and owners in the same business types (excluded from the trial) conducted in an earlier part of the study, as well as a community advisory group (e.g., Hispanic Chamber of Commerce) .
From this, we will generate educational materials specific for each small business sector.
We will provide the CHWs with a list of industry-specific control options along with potential cost savings and benefits.
For example, EPA estimates a cost saving of $13,000 per year for auto body shops that switch to the high-velocity low-pressure spray guns.
Each list will be a comprehensive menu of options that contain multiple control measures including simple controls, such as keeping the lids on the solvent containers.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Volatile Organic Chemical Concentrations From Pre- to Post-Intervention
Time Frame: 6 months
|
The primary outcome is the change in average total volatile organic chemical exposures for each business from pre- to post- intervention.
|
6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
General Publications
- Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, Ogedegbe G, Orwig D, Ernst D, Czajkowski S; Treatment Fidelity Workgroup of the NIH Behavior Change Consortium. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004 Sep;23(5):443-51. doi: 10.1037/0278-6133.23.5.443.
- Davidson KW, Goldstein M, Kaplan RM, Kaufmann PG, Knatterud GL, Orleans CT, Spring B, Trudeau KJ, Whitlock EP. Evidence-based behavioral medicine: what is it and how do we achieve it? Ann Behav Med. 2003 Dec;26(3):161-71. doi: 10.1207/S15324796ABM2603_01.
- Kraemer HC, Kuchler T, Spiegel D. Use and misuse of the consolidated standards of reporting trials (CONSORT) guidelines to assess research findings: comment on Coyne, Stefanek, and Palmer (2007). Psychol Bull. 2009 Mar;135(2):173-8; discussion 179-82. doi: 10.1037/0033-2909.135.2.173.
- Campbell MK, Elbourne DR, Altman DG; CONSORT group. CONSORT statement: extension to cluster randomised trials. BMJ. 2004 Mar 20;328(7441):702-8. doi: 10.1136/bmj.328.7441.702. No abstract available.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- R01ES028250 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Volatile Organic Compounds
-
NCT04856995CompletedOccupational Health | Volatile Organic Compounds | Air Quality
-
NCT03967652Not yet recruitingCancer | Diagnoses Disease | Volatile Organic Compounds
-
NCT04226079UnknownGastrointestinal Hemorrhage | Volatile Organic Compounds
-
NCT03414580UnknownInflammatory Bowel Disease | Volatile Organic Compounds
-
NCT05412758RecruitingGastric Cancer | Oesophageal Cancer | Microbiome | Volatile Organic Compounds | Transcriptomics | Microbioata | Breath Analysis | Volatalomics | Metabonomics/Lipidomics | Microbiome Analysis
-
NCT06175429RecruitingMuscle Weakness | Frailty | Volatile Organic Compounds | Isoprene
-
NCT04407325RecruitingRadiography | Volatile Organic Compounds
-
NCT01261338CompletedToxic Effect of Other Corrosive Organic Compounds
-
NCT01239238CompletedAsthma | Children | Volatile Organic Compounds | Exhaled Breath Condensate | Home Monitoring | Non-invasive Inflammatory Markers
-
NCT05982912RecruitingInvasive Pulmonary Aspergillosis | Volatile Organic Compounds | Breath Samples
Clinical Trials on Industrial Hygiene-Enhance Community Health Worker Intervention
-
NCT06156254RecruitingCOVID-19 Vaccination
-
NCT02152852CompletedType 2 Diabetes
-
NCT06510075RecruitingPregnancy Complications | Infant Conditions | Maternal Distress | Adverse Birth Outcomes
-
NCT05774314Recruiting
-
NCT05068505CompletedHypertension; Community Health Workers
-
NCT05694546CompletedHIV/AIDS | Opportunistic Infections | Hospitalization | Transitions of Care
-
NCT00457522CompletedIntimate Partner Violence
-
NCT05940688CompletedPregnancy | Disparities | Infants
-
NCT00998595CompletedDiabetes, Gestational | Postpartum Period